Development of Hepatocellular Carcinoma in Patients Aged 75–84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals

BACKGROUND: Direct-acting antiviral (DAA) treatment has revolutionized hepatitis C virus (HCV) care. We aimed to evaluate the risk for the development of hepatocellular carcinoma (HCC) in patients aged 75–84 years with chronic hepatitis C after HCV elimination. METHODS: This multicenter cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Eiichi, Nomura, Hideyuki, Nakamuta, Makoto, Furusyo, Norihiro, Kajiwara, Eiji, Dohmen, Kazufumi, Kawano, Akira, Ooho, Aritsune, Azuma, Koichi, Takahashi, Kazuhiro, Satoh, Takeaki, Koyanagi, Toshimasa, Ichiki, Yasunori, Kuniyoshi, Masami, Yanagita, Kimihiko, Amagase, Hiromasa, Morita, Chie, Sugimoto, Rie, Kato, Masaki, Shimoda, Shinji, Hayashi, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417129/
https://www.ncbi.nlm.nih.gov/pubmed/32584386
http://dx.doi.org/10.1093/infdis/jiaa359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417129/
https://www.ncbi.nlm.nih.gov/pubmed/32584386
http://dx.doi.org/10.1093/infdis/jiaa359

Ejemplares similares